scholarly journals Targeted Learning for Pre-Analysis Plans in Public Health and Health Policy Research

2015 ◽  
Vol 1 (2) ◽  
pp. 294-306
Author(s):  
Sherri Rose
2019 ◽  
pp. 277-290
Author(s):  
Tim Doran ◽  
Richard Cookson

The determinants of health inequality have become increasingly well understood, but policy makers have repeatedly failed to address the issue effectively, and many public health interventions unintentionally worsen inequalities because they disproportionately benefit those with greater resources. This is a policy failure, but it is also a scientific failure. Although policy makers often understand that their decisions have differential impacts across society, the analytical tools used to inform policy lack a substantial perspective on equity, focusing on averages rather than social distributions, leading to inequitable solutions. In an age of social division driven by rising inequality, rigorous new methods for precisely measuring the equity impacts of health and social policy interventions are required, drawing on new partnerships between researchers across disciplines. By developing these methods, and using them to assess the effectiveness of major public health and healthcare initiatives, researchers can improve understanding of the structural, behavioural and organizational barriers to delivering equitable health outcomes. Policy makers will then have the necessary information to judge who gains and who loses from their decisions.


BMJ Open ◽  
2020 ◽  
Vol 10 (7) ◽  
pp. e034082 ◽  
Author(s):  
Melissa Mialon ◽  
Stefanie Vandevijvere ◽  
Angela Carriedo-Lutzenkirchen ◽  
Lisa Bero ◽  
Fabio Gomes ◽  
...  

ObjectiveWe identified mechanisms for addressing and/or managing the influence of corporations on public health policy, research and practice, as well as examples of where these mechanisms have been adopted from across the globe.DesignWe conducted a scoping review. We conducted searches in five databases on 4 June 2019. Twenty-eight relevant institutions and networks were contacted to identify additional mechanisms and examples. In addition, we identified mechanisms and examples from our collective experience working on the influence of corporations on public health policy, research and practice.SettingWe identified mechanisms at the national, regional and global levels.ResultsThirty-one documents were included in our review. Eight were peer-reviewed scientific articles. Nine discussed mechanisms to address and/or manage the influence of different types of industries; while other documents targeted specific industries. In total, we identified 49 mechanisms for addressing and/or managing the influence of corporations on public health policy, research and practice, and 43 of these were adopted at the national, regional or global level. We identified four main types of mechanisms: transparency; management of interactions with industry and of conflicts of interest; identification, monitoring and education about the practices of corporations and associated risks to public health; prohibition of interactions with industry. Mechanisms for governments (n=17) and academia (n=13) were most frequently identified, with fewer for the media and civil society.ConclusionsWe identified several mechanisms that could help address and/or manage the negative influence of corporations on public health policy, research and practice. If adopted and evaluated more widely, many of the mechanisms described in this manuscript could contribute to efforts to prevent and control non-communicable diseases.Trial registration detailsThe protocol was registered with the Open Science Framework on 27 May 2019 (https://osf.io/xc2vp).


2019 ◽  
Vol 8 (1) ◽  
Author(s):  
Bruce Rosen ◽  
Avi Israeli ◽  
Stephen Schoenbaum

AbstractThe Israel Journal of Health Policy Research (IJHPR) is a peer-reviewed, on-line, open access journal, sponsored by Israel’s National Institute for Health Policy Research. We believe that it is both an innovative platform and a platform for innovation. Within just 2 years of its launch in 2012, the IJHPR was accepted into the prestigious Web of Science – primarily because of its innovative positioning as a journal that is simultaneously national and international. This positioning has contributed to annual growth of over 20% in both submissions and publications and to the IJHPR being ranked among the top half of public health journals, just 6 years after its launch date.The IJHPR has also served as a platform for numerous innovations, including: Sharing with the international community information about Israeli innovations in public health, health policy, health care delivery, and more.Enhancing the impact of empirical studies by Israeli scholars via commentaries by leading scholars from abroad – including 18 commentaries from scholars based at Harvard and one commentary by a Nobel laureate in economics.Developing a new genre of articles for Israel, namely, broad policy analyses focused on major challenges facing Israeli health care.Creating dynamic, constantly growing, article collections in such fields as digital health, pharmaceutical policy and health care equity, to highlight areas of excellence as well as important issues in Israeli health care and health policy.Disseminating to a wide audience the essence of major Israeli health policy workshops and conferences.We feel that the IJHPR has significant potential to contribute more, and in new ways, in the years ahead. We look forward to your suggestions for innovative enhancements of the IJHPR.


2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Rima Nakkash ◽  
Melissa Mialon ◽  
Jihad Makhoul ◽  
Monika Arora ◽  
Rima Afifi ◽  
...  

AbstractEfforts to adopt public health policies that would limit the consumption of unhealthy commodities, such as tobacco, alcohol and ultra-processed food products, are often undermined by private sector actors whose profits depend on the sales of such products. There is ample evidence showing that these corporations not only try to influence public health policy; they also shape research, practice and public opinion. Globalization, trade and investment agreements, and privatization, amongst other factors, have facilitated the growing influence of private sector actors on public health at both national and global levels. Protecting and promoting public health from the undue influence of private sector actors is thus an urgent task. With this backdrop in mind, we launched the “Governance, Ethics, and Conflicts of Interest in Public Health” Network (GECI-PH Network) in 2018. Our network seeks to share, collate, promote and foster knowledge on governance, ethical, and conflicts of interest that arise in the interactions between private sectors actors and those in public health, and within multi-stakeholder mechanisms where dividing lines between different actors are often blurred. We call for strong guidance to address and manage the influence of private sector actors on public health policy, research and practice, and for dialogue on this important topic. Our network recently reached 119 members. Membership is diverse in composition and expertise, location, and institutions. We invite colleagues with a common interest to join our network.


Sign in / Sign up

Export Citation Format

Share Document